The FDA approved zilurgisertib tablets for the reduction of heterotopic ossification among patients aged 12 years or older ...
Remigromig was noninferior to ranibizumab at 52 weeks in patients with diabetic macular edema, according to a press release ...
It can cost more than $10,000 to translate an informed consent form for a clinical trial into another language, according to ...
A healthy 14-year-old girl is seen after several days of gradually worsening pain and swelling on the left side of her face.
An FDA advisory panel expressed support for a blood test designed to detect early signs of multiple cancers, including some ...
Established evidence has long supported the use of red light therapy for radiation oncology, but emerging data suggest ...
Senators asked Heidi Overton, MD, about some critical issues in medicine during her hearing to become FDA commissioner.If ...
As an attorney and wealth advisor to physicians for 30 years, there is one reality I have not seen change over my career: doctors of all specialties and stages of career want to reduce taxes wherever ...
CMS said it is taking action to combat alleged fraud in the Affordable Care Act program.One expert told Healio the move could ...
The FDA approved obinutuzumab for the treatment of idiopathic nephrotic syndrome in pediatric patients aged 2 years and older ...
The FDA has approved a once-weekly basal insulin to control glucose levels for adults with type 2 diabetes, Eli Lilly ...
Ioannis Pallikaris, MD, PhD, a pioneering leader in the development of LASIK, delivered this year’s ESCRS Heritage Lecture ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results